Hepatocellular Carcinoma: The Role of MicroRNAs
Open Access
- 27 April 2022
- journal article
- review article
- Published by MDPI AG in Biomolecules
- Vol. 12 (5) , 645
Abstract
Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related deaths worldwide. HCC is diagnosed in its advanced stage when limited treatment options are available. Substantial morphologic, genetic and epigenetic heterogeneity has been reported in HCC, which poses a challenge for the development of a targeted therapy. In this review, we discuss the role and involvement of several microRNAs (miRs) in the heterogeneity and metastasis of hepatocellular carcinoma with a special emphasis on their possible role as a diagnostic and prognostic tool in the risk prediction, early detection, and treatment of hepatocellular carcinoma.Keywords
Funding Information
- Cancer Research Endowment
This publication has 198 references indexed in Scilit:
- Evolution of the cancer genomeNature Reviews Genetics, 2012
- Intratumoral Heterogeneity of MicroRNA Expression in Breast CancerThe Journal of Molecular Diagnostics, 2012
- Intra-tumour heterogeneity: a looking glass for cancer?Nature Reviews Cancer, 2012
- Construction of an Oncolytic Herpes Simplex Virus That Precisely Targets Hepatocellular Carcinoma CellsMolecular Therapy, 2012
- An HNF4α-miRNA Inflammatory Feedback Circuit Regulates Hepatocellular OncogenesisCell, 2011
- MicroRNAs in body fluids—the mix of hormones and biomarkersNature Reviews Clinical Oncology, 2011
- Silencing of microRNA families by seed-targeting tiny LNAsNature Genetics, 2011
- IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockageJournal of Hepatology, 2010
- Transcriptional Control of Gene Expression by MicroRNAsCell, 2010
- Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer ModelCell, 2009